CBD is a Schedule 4 (Prescription Only) medicine in Australia when CBD makes up 98% or more of the cannabinoids in the product.1 A Schedule 3 (Pharmacist Only) entry also exists for low-dose CBD, but no product has qualified for it, and products with more than 2% other cannabinoids are Schedule 8.12
What is a schedule?
The Poisons Standard is a national legal instrument that sorts medicines and chemicals into numbered schedules. Each schedule sets how a substance can be supplied. The states and territories give the schedules legal force through their own laws. The current edition commenced on 1 October 2026.1
How do the three CBD schedules compare?
| Schedule 3 | Schedule 4 | Schedule 8 | |
|---|---|---|---|
| Label | Pharmacist Only Medicine | Prescription Only Medicine | Controlled Drug |
| Prescription needed | No | Yes | Yes, with tighter controls |
| CBD share of cannabinoids | 98% or more | 98% or more | Under 98% |
| Products available, November 2026 | None | Yes, on prescription | Yes, on prescription |
The Schedule 3 and 4 rows come from the Poisons Standard entries. The Schedule 8 row follows when those entries are read with the cannabis and THC entries.1
Why is there no Schedule 3 CBD on sale?
The Schedule 3 entry only covers products “included in the Register”, meaning the Australian Register of Therapeutic Goods. It also requires a maximum daily dose of 150 mg, oral use only, and adults only.1 A product that meets the other conditions but is not registered stays in Schedule 4.1 The Therapeutic Goods Administration (TGA) said in August 2025 that no complete application for such a product had been submitted.2 See can you buy CBD at a chemist?
When is a CBD product Schedule 8?
When cannabinoids other than CBD make up more than 2% of the total. The TGA’s “CBD-dominant” category, where CBD is 60% to under 98% of cannabinoids, is Schedule 8.34 So a product marketed for its CBD can still be a controlled drug.
Is anything exempt?
Only hemp seed oil with 75 mg/kg or less of CBD and 10 mg/kg or less of THC.1 See is CBD oil the same as hemp oil?
Could the schedule change?
Possibly. The TGA has said reform options “may include a review of the current scheduling of cannabis, CBD and THC”. No decision had been made as of the latest documents we found.5
Read the full guide: Schedule 3, 4 and 8 explained.
Footnotes
-
Australian Government. Therapeutic Goods (Poisons Standard, October 2026) Instrument 2026. https://www.legislation.gov.au/F2026L01327/asmade/2026-09-30/text/original/pdf ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7
-
Therapeutic Goods Administration. Consultation paper: reviewing the safety and regulatory oversight of unapproved medicinal cannabis products, August 2025. https://consultations.tga.gov.au/medicines-regulation-division/test-soms/user_uploads/final---consultation-paper---medicinal-cannabis-review---august-2025.pdf ↩ ↩2
-
Penington Institute. Cannabis in Australia, November 2025 (restating the TGA category scheme). https://www.penington.org.au/wp-content/uploads/2025/11/Penington_Institute_Cannabis-in-Australia_Nov_2025.pdf ↩
-
Therapeutic Goods Administration. Medicinal cannabis (unapproved therapeutic goods). https://www.tga.gov.au/products/unapproved-therapeutic-goods/medicinal-cannabis ↩
-
Therapeutic Goods Administration. Paper to the scheduling advisory committee, 18 March 2026, released as FOI 26-2886. https://www.tga.gov.au/sites/default/files/2026-06/FOI%2026-2886.PDF ↩
This page is general information, not medical or legal advice. Laws and evidence change; we show the date we last checked the facts at the top of every page. Talk to your doctor or pharmacist before starting, stopping or changing any medicine.
Didn't find what you needed? Ask us a question.
Get the monthly update
One short email a month: what changed in Australian CBD law, regulation and research, and which guides we updated. No advertising. Unsubscribe any time. (As of November 2026 we are collecting sign-ups; the first update has not been sent yet.)